fbpx

In the press

QuotedData’s input into Investors Chronicle’s Top 100 Funds

Biotech trust Trump benefit may be shortlived

Top 100 Funds 2019: Specialist equity funds

By Leonora Walters

If you have a large portfolio and a higher risk appetite, you could consider adding a small allocation to some specialist equities funds focused on a particular area that could benefit from high growth…

NEW ENTRANT:Polar Capital Global Insurance(IE00B61MW553): Insurance company equities can be a good way to diversify the equity portion of your portfolio as they can be more defensive than the broader market..

NEW ENTRANT: International Biotechnology Trust(IBT): Mr Liddell and Mr Carthew suggested adding International Biotechnology Trust. Its managers invest in companies they think have good growth prospects, with experienced management teams and strong potential upside through the development and/or commercialisation of a product, device or enabling technology…

Worldwide Healthcare Trust(WWH): Worldwide Healthcare Trust invests in both the healthcare and higher-return, higher-risk biotechnology sector…

Polar Capital Technology Trust(PCT): Polar Capital Technology Trust has beaten Dow Jones World Technology index in net asset value terms over one, three and five years…

Allianz Technology Trust (ATT): Allianz Technology Trust has a good record of beating the Dow Jones World Technology index and the returns of other technology trusts…

Jupiter Financial Opportunities(GB00B5LG4657): Jupiter Financial Opportunities, which has been run by Guy de Blonay since January 2011, has beaten its benchmark, MSCI ACWI Financials index over one, three and five years, as well as broader global benchmarks such as MSCI World index and the IA Global fund sector average…

BlackRock World Mining Trust(BRWM): BlackRock World Mining Trust’s returns have been very volatile, in keeping with the assets it mainly invests in – the shares of mining companies involved with a range of materials including copper and gold…

FUNDS DROPPED: Biotech Growth Trust (BIOG)

Two of our panellists, Mr Carthew and Mr Liddell, suggested dropping Biotech Growth Trust in favour of International Biotechnology Trust (see above). Biotech Growth Trust has underperformed International Biotechnology over one, three and five years…

“Since Sam Isaly departed Orbimed, both Worldwide Healthcare and Biotech Growth have struggled a bit,” says Mr Carthew. “I’d keep the former, larger trust on the list but replace Biotech Growth with International Biotechnology, which seems to be establishing a much stronger track record.”

Read more here

NULL